Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:1528  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 

    Article Cited by others

UPDATE ARTICLE

Human immunodeficiency virus and leishmaniasis

Ezra Navid, Ochoa Maria Teresa, Craft Noah

Year : 2010| Volume: 2| Issue : 3 | Page no: 248-257

   This article has been cited by
 
1 Potential therapeutic targets shared between leishmaniasis and cancer
Sajad Rashidi, Celia Fernández-Rubio, Raúl Manzano-Román, Reza Mansouri, Reza Shafiei, Mohammad Ali-Hassanzadeh, Afshin Barazesh, Mohammadreza Karimazar, Gholamreza Hatam, Paul Nguewa
Parasitology. 2021; 148(6): 655
[Pubmed]  [Google Scholar] [DOI]
2 A Case–Control Study on the Association Between Intestinal Helminth Infections and Treatment Failure in Patients With Cutaneous Leishmaniasis
Dalila Y Martínez, Alejandro Llanos-Cuentas, Jean-Claude Dujardin, Katja Polman, Vanessa Adaui, Marleen Boelaert, Kristien Verdonck
Open Forum Infectious Diseases. 2020; 7(5): 883
[Pubmed]  [Google Scholar] [DOI]
3 Higher levels of TNF and IL-4 cytokines and low miR-182 expression in visceral leishmaniasis-HIV co-infected patients
Walter Lins Barbosa Júnior, Alda Maria Justo, Ana Maria Aguiar dos Santos, Virginia Maria Barros Lorena, Rodrigo Feliciano Carmo, Fábio Lopes Melo, Zulma Maria Medeiros, Luydson Richardson Silva Vasconcelos
Parasite Immunology. 2020; 42(4)
[Pubmed]  [Google Scholar] [DOI]
4 Fluralaner (Bravecto®) induces long-term mortality of Lutzomyia longipalpis after a blood meal in treated dogs
Tamyres Bernadete Dantas Queiroga, Henrique Rafael Pontes Ferreira, Wilo Victor dos Santos, Ana Beatriz Lourenço de Assis, Vicente Toscano de Araújo Neto, Antônia Cláudia Jácome da Câmara, João Ciro Fagundes Neto, Romeika Karla dos Reis, Manuela Sales Lima Nascimento, Renata Antonaci Gama, Paulo Marcos Matta Guedes
Parasites & Vectors. 2020; 13(1)
[Pubmed]  [Google Scholar] [DOI]
5 CASE REPORT: A TEN YEAR GIRL WAS DIAGNOSED VISCERAL LEISHMANIASIS COINFECTION WITH HIV POSITIVEIN THE HOSPITAL OF HUE UNIVERSITY OF MEDICINE AND PHARMACY
Nu Phuong Anh Ton, Thi Minh Chau Ngo, Chi Cao Le, Thi Bich Thao Do, Hung Viet Phan, Nu Thuy Duong Ha
Journal of Medicine and Pharmacy. 2019; : 106
[Pubmed]  [Google Scholar] [DOI]
6 Spectrum of clinicohematological profile and its correlation with average parasite density in visceral leishmaniasis
Vijay Kumar, Poojan Agarwal, Sadhna Marwah, A. S. Nigam, Awantika Tiwari
CytoJournal. 2018; 15: 19
[Pubmed]  [Google Scholar] [DOI]
7 Indian visceral leishmaniasis with extensive lymphadenopathy – An unusual presentation: A case report with literature review
Poojan Agarwal, Vijay Kumar, Manju Kaushal, Manju Kumari, Arvind Chaudhary
CytoJournal. 2017; 14: 9
[Pubmed]  [Google Scholar] [DOI]
8 Immunity to visceral leishmaniasis: implications for immunotherapy
Forough Khadem,Jude E Uzonna
Future Microbiology. 2014; 9(7): 901
[Pubmed]  [Google Scholar] [DOI]
9 Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV/AIDS Patients
Eltahir Awad Gasim Khalil,Selma Abdelmoneim Khidir,Ahmed Mudawi Musa,Brema Younis Musa,Mona Elfaki Eltahir Elfaki,Abdelgadir Mohamed Yousif Elkadaru,Edward Zijlstra,Ahmed Mohamed El-Hassan
Journal of Tropical Medicine. 2013; 2013: 1
[Pubmed]  [Google Scholar] [DOI]
10 Inhibitory effect of citrinin on lipopolisaccharide-induced nitric oxide production by mouse macrophage cells
Kei-ichi Sugiyama,Rino Yamazaki,Mawo Kinoshita,Yoichi Kamata,Fumito Tani,Yuji Minai,Yoshiko Sugita-Konishi
Mycotoxin Research. 2013; 29(4): 229
[Pubmed]  [Google Scholar] [DOI]
11 Visceral leishmaniasis: host–parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host
Laura Saporito,Giovanni M. Giammanco,Simona De Grazia,Claudia Colomba
International Journal of Infectious Diseases. 2013; 17(8): e572
[Pubmed]  [Google Scholar] [DOI]
12 Epidemiology of human immunodeficiency virus-visceral leishmaniasis-co-infection
Patrícia Rodrigues Naufal Spir,Lourdes Aparecida Zampieri DæAndrea,Elivelton Silva Fonseca,Luiz Euribel Prestes-Carneiro
Journal of Microbiology, Immunology and Infection. 2013;
[Pubmed]  [Google Scholar] [DOI]
13 Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: results of a large cross-sectional study
Omer Bébé Ngouateu,Pierre Kollo,Christophe Ravel,Jacques Dereure,Pierre Kamtchouing,Albert Same-Ekobo,Esther von Stebut,Marcus Maurer,Blaise Dondji
Transactions of the Royal Society of Tropical Medicine and Hygiene. 2012; 106(3): 137
[Pubmed]  [Google Scholar] [DOI]
14 Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection
S.A. Campbell,J. Alawa,B. Doro,F.L. Henriquez,C.W. Roberts,A. Nok,C.B.I. Alawa,M. Alsaadi,A.B. Mullen,K.C. Carter
Vaccine. 2012; 30(7): 1357
[Pubmed]  [Google Scholar] [DOI]
15 Leishmaniasis visceral insospechada infiltrando un carcinoma epidermoide
M. Armengot-Carbó,R. Carmena-Ramón,B. Rodrigo-Nicolás,J. Ferrando-Marco
Actas Dermo-Sifiliográficas. 2012; 103(4): 321
[Pubmed]  [Google Scholar] [DOI]
16 Unsuspected Visceral Leishmaniasis Infiltrating a Squamous Cell Carcinoma
M. Armengot-Carbó,R. Carmena-Ramón,B. Rodrigo-Nicolás,J. Ferrando-Marco
Actas Dermo-Sifiliográficas (English Edition). 2012; 103(4): 321
[Pubmed]  [Google Scholar] [DOI]
17 Leishmaniasis with oral mucosa involvement
Ana C. A. Pellicioli,Marco A. T. Martins,Manoel Sant’ana Filho,Pantelis V. Rados,Manoela D. Martins
Gerodontology. 2012; 29(2): e1168
[Pubmed]  [Google Scholar] [DOI]
18 Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems
Delaram Doroud,Sima Rafati
Expert Review of Vaccines. 2012; 11(1): 69
[Pubmed]  [Google Scholar] [DOI]
19 Disseminated rhodococcus equi infection in HIV infection despite highly active antiretroviral therapy
Francesca Ferretti,Antonio Boschini,Cristiana Iabichino,Simonetta Gerevini,Paola De Nardi,Monica Guffanti,Giuseppe Balconi,Adriano Lazzarin,Paola Cinque
BMC Infectious Diseases. 2011; 11(1): 343
[Pubmed]  [Google Scholar] [DOI]
20 Clinical pleiomorphism in human leishmaniases, with special mention of asymptomatic infection
A. L. Bañuls,P. Bastien,C. Pomares,J. Arevalo,R. Fisa,M. Hide
Clinical Microbiology and Infection. 2011; 17(10): 1451
[Pubmed]  [Google Scholar] [DOI]
21 Innate Immunity and Leishmania Vaccination Strategies
Ron Birnbaum,Noah Craft
Dermatologic Clinics. 2011; 29(1): 89
[Pubmed]  [Google Scholar] [DOI]
22 Activity and turnover of eosinophil and neutrophil granulocytes are altered in visceral leishmaniasis
Amir I. Elshafie,Erik Åhlin,Lena Douhan Håkansson,Gehad Elghazali,Sayda Hassan El Safi,Johan Rönnelid,Per Venge
International Journal for Parasitology. 2011; 41(3-4): 463
[Pubmed]  [Google Scholar] [DOI]
23 PLGA nanoparticles loaded with the antileishmanial saponin ß-aescin: Factor influence study and in vitro efficacy evaluation
H. Van de Ven,M. Vermeersch,A. Matheeussen,J. Vandervoort,W. Weyenberg,S. Apers,P. Cos,L. Maes,A. Ludwig
International Journal of Pharmaceutics. 2011; 420(1): 122
[Pubmed]  [Google Scholar] [DOI]

 

Read this article
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008